Please login to the form below

Not currently logged in

Both AZ and J&J set to resume US COVID-19 vaccine trials

Vaccine vialBoth companies paused their trials after separate participant illness events

AZ’s COVID-19 vaccine shows promise in younger and older adults

AstraZeneca AZCompany said vaccine produces similar immune response in younger and older adults

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

GileadAntiviral drug initially scored emergency use authorisation in May

Vaccine developers call on FDA to offer clarity on COVID-19 trials

Coronavirus vaccineComments from J&J and Pfizer made before FDA advisory committee meeting yesterday

Moderna completes enrolment of phase 3 COVID-19 vaccine trial

Late-stage study hits 30,000 participant target

Purdue to pay over $8bn to settle opioid-related criminal claims

US Senate - Capitol buildingClaims relate to Purdue's involvement in fuelling the opioid addiction crisis

Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

CoronavirusNew developments for COVID-19 treatments and vaccines

AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death

covidReports indicate that the death occurred in the placebo group

Caroline GoslingQ&A: Caroline Gosling

PME interviews Rubica's Director of Culture & Engagement

Latest appointments

COVID-19 Updates and Daily News

Featured jobs


Add my company

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...